Investigation of Systemic Metal Ion Concentration Following a Ceramic-on-metal Total Hip Arthroplasty

NCT ID: NCT00883805

Last Updated: 2015-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study to compare systemic concentrations of cobalt and chromium in patients that have previously undergone total hip arthroplasties with ceramic on metal and metal on metal bearing surfaces.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a pilot study to compare systemic concentrations of cobalt and chromium in patients that have previously undergone total hip arthroplasties with ceramic on metal and metal on metal bearing surfaces. Secondary goals include an assessment of osteolysis on radiographs, potential long term analysis of implant survivability, and cancer rates in the two patient populations.

Increased metal ion production has been documented in metal-on-metal arthroplasty articulations. There are several concerns over metal ion production. First, even though there is a decreased histiocytic response to metallic debris, a dose dependent cytotoxic response with Interleukin 6, Prostaglandin E2, and Tumor Necrosis Factor alpha persists and may cause osteolysis in the long term. Second, increased levels of cobalt, chromium and nickel has been shown to correlate with increased cancer rates in several animal models, and the carcinogenic risk in humans has not been fully elucidated as yet. Third, hypersensitivity reactions to metal ion develop in up to 25% of these patients, and 60% of patients with poorly functioning hip.

Ceramic on metal avoids many of these problems due to the improved wear characteristics. If the level of metal ion production is significantly reduced and the implant survivability is proven in long term studies, this articulation may become the preferred method.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Replacement Hip Implant Total Hip Arthroplasty Orthopaedic Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Metal-on-Metal Articulations

Subjects will be people who have had metal-on-metal total hip arthroplasties

Blood draw

Intervention Type BIOLOGICAL

Subjects will give blood for analysis of metal ion concentrations

X-Ray of Hip

Intervention Type RADIATION

Subject will have x-ray of hip to assessment of osteolysis

Ceramic-on-Metal Articulations

Subjects will be people who have had ceramic-on-metal total hip arthroplasties

Blood draw

Intervention Type BIOLOGICAL

Subjects will give blood for analysis of metal ion concentrations

X-Ray of Hip

Intervention Type RADIATION

Subject will have x-ray of hip to assessment of osteolysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood draw

Subjects will give blood for analysis of metal ion concentrations

Intervention Type BIOLOGICAL

X-Ray of Hip

Subject will have x-ray of hip to assessment of osteolysis

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is 40 - 80, who has undergone a top hip arthroplasty with either metal on metal or ceramic on metal articulation for a diagnosis of non-inflammatory degenerative joint disease. We will also include subjects who have had bilateral hip arthroplasties or a second arthroplasty performed since the initial surgery.
* Patient must be able to provide consent to participate

Exclusion Criteria

* Diagnosis other than non-inflammatory degenerative joint disease, chronic renal insufficiency, or any systemic inflammatory condition
* Evidence of active infections
* Patients whose occupations include welding or metal working
* A second arthroplasty performed since the initial will not be exclude, but their data will be analyzed as a subpopulation
* unwillingness to comply with rehabilitation program or inability to return for follow-up visits
* Any systemic steroid therapy within 3 months of surgery
* Subjects who are pregnant
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwell Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniel Grande

director:orthopaedic research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel Grande, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Feinstein Institute for Medical Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Feinstein Institute for Medical Research

Manhasset, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB# 07-08-105

Identifier Type: -

Identifier Source: secondary_id

GCRC 0163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mineral Nano Pathology
NCT03898531 COMPLETED